-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Mortality -X- _ O
is -X- _ O
high -X- _ O
among -X- _ O
patients -X- _ O
with -X- _ O
Middle -X- _ O
East -X- _ O
Respiratory -X- _ O
Syndrome -X- _ O
Coronavirus -X- _ O
( -X- _ O
MERS-CoV -X- _ O
) -X- _ O
infection. -X- _ O
We -X- _ O
aimed -X- _ O
to -X- _ O
determine -X- _ O
hospital -X- _ O
mortality -X- _ O
and -X- _ O
the -X- _ O
factors -X- _ O
associated -X- _ O
with -X- _ O
it -X- _ O
in -X- _ O
a -X- _ O
cohort -X- _ O
of -X- _ O
MERS-CoV -X- _ B-Patient
patients. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
We -X- _ O
reviewed -X- _ O
hospital -X- _ O
records -X- _ O
of -X- _ O
confirmed -X- _ O
cases -X- _ O
( -X- _ O
detection -X- _ O
of -X- _ O
virus -X- _ O
by -X- _ O
polymerase -X- _ O
chain -X- _ O
reaction -X- _ O
from -X- _ O
respiratory -X- _ O
tract -X- _ O
samples -X- _ O
) -X- _ O
of -X- _ O
MERS-CoV -X- _ O
patients -X- _ O
( -X- _ O
n -X- _ O
= -X- _ O
63 -X- _ O
) -X- _ O
admitted -X- _ O
to -X- _ O
Buraidah -X- _ O
Central -X- _ O
Hospital -X- _ O
in -X- _ O
Al-Qassim -X- _ O
, -X- _ O
Saudi -X- _ O
Arabia -X- _ O
between -X- _ O
2014 -X- _ O
and -X- _ O
2017. -X- _ O
We -X- _ O
abstracted -X- _ O
data -X- _ O
on -X- _ O
demography -X- _ O
, -X- _ O
vital -X- _ O
signs -X- _ O
, -X- _ O
associated -X- _ O
conditions -X- _ O
presented -X- _ O
on -X- _ O
admission -X- _ O
, -X- _ O
pre-existing -X- _ O
chronic -X- _ O
diseases -X- _ O
, -X- _ O
treatment -X- _ O
, -X- _ O
and -X- _ O
vital -X- _ O
status. -X- _ O
Bi-variate -X- _ O
comparisons -X- _ O
and -X- _ O
multiple -X- _ O
logistic -X- _ O
regressions -X- _ O
were -X- _ O
the -X- _ O
choice -X- _ O
of -X- _ O
data -X- _ O
analyses. -X- _ O
RESULTS -X- _ O
: -X- _ O
The -X- _ B-Outcome
mean -X- _ I-Outcome
age -X- _ I-Outcome
was -X- _ I-Outcome
60 -X- _ I-Outcome
years -X- _ I-Outcome
( -X- _ I-Outcome
SD -X- _ I-Outcome
= -X- _ I-Outcome
18.2 -X- _ I-Outcome
) -X- _ I-Outcome
; -X- _ I-Outcome
most -X- _ I-Outcome
patients -X- _ I-Outcome
were -X- _ I-Outcome
male -X- _ I-Outcome
( -X- _ I-Outcome
74.6 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
Saudi -X- _ I-Outcome
citizens -X- _ I-Outcome
( -X- _ I-Outcome
81 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
All -X- _ I-Outcome
but -X- _ I-Outcome
two -X- _ I-Outcome
patients -X- _ I-Outcome
were -X- _ I-Outcome
treated -X- _ I-Outcome
with -X- _ I-Outcome
Ribavirin -X- _ I-Outcome
plus -X- _ I-Outcome
Interferon. -X- _ I-Outcome
Hospital -X- _ I-Outcome
mortality -X- _ I-Outcome
was -X- _ I-Outcome
25.4 -X- _ I-Outcome
% -X- _ I-Outcome
. -X- _ I-Outcome
Patients -X- _ I-Outcome
who -X- _ I-Outcome
were -X- _ I-Outcome
admitted -X- _ I-Outcome
with -X- _ I-Outcome
septic -X- _ I-Outcome
shock -X- _ I-Outcome
and -X- _ I-Outcome
/ -X- _ I-Outcome
or -X- _ I-Outcome
organ -X- _ I-Outcome
failure -X- _ I-Outcome
were -X- _ I-Outcome
significantly -X- _ I-Outcome
more -X- _ I-Outcome
likely -X- _ I-Outcome
to -X- _ I-Outcome
die -X- _ I-Outcome
than -X- _ I-Outcome
patients -X- _ I-Outcome
who -X- _ I-Outcome
were -X- _ I-Outcome
admitted -X- _ I-Outcome
with -X- _ I-Outcome
pneumonia -X- _ I-Outcome
and -X- _ I-Outcome
/ -X- _ I-Outcome
or -X- _ I-Outcome
acute -X- _ I-Outcome
respiratory -X- _ I-Outcome
distress -X- _ I-Outcome
syndrome -X- _ I-Outcome
( -X- _ I-Outcome
OR -X- _ I-Outcome
= -X- _ I-Outcome
47.9 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
= -X- _ I-Outcome
3.9 -X- _ I-Outcome
, -X- _ I-Outcome
585.5 -X- _ I-Outcome
, -X- _ I-Outcome
p-value -X- _ I-Outcome
0.002 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Age -X- _ I-Outcome
, -X- _ I-Outcome
sex -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
presence -X- _ I-Outcome
of -X- _ I-Outcome
chronic -X- _ I-Outcome
conditions -X- _ I-Outcome
were -X- _ I-Outcome
not -X- _ I-Outcome
significantly -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
mortality. -X- _ I-Outcome
CONCLUSION -X- _ O
: -X- _ O
Hospital -X- _ B-Outcome
mortality -X- _ I-Outcome
was -X- _ I-Outcome
25 -X- _ I-Outcome
% -X- _ I-Outcome
; -X- _ I-Outcome
septic -X- _ I-Outcome
shock -X- _ I-Outcome
/ -X- _ I-Outcome
organ -X- _ I-Outcome
failure -X- _ I-Outcome
at -X- _ I-Outcome
admittance -X- _ I-Outcome
was -X- _ I-Outcome
a -X- _ I-Outcome
significant -X- _ I-Outcome
predictor -X- _ I-Outcome
of -X- _ I-Outcome
mortality -X- _ I-Outcome
. -X- _ O

